|
| Zydus, Ashok Leyland & Oil India Q1 result |
| BS Reporter / Ahmedabad/ Chennai/ New Delhi Jul 28, 2010, 01:36 IST |
|
Zydus PAT up 60 per cent
Zydus Cadila, the Ahmedabad-based pharma major, posted a 60 per cent rise in net profit to Rs 199 crore in the first quarter of this financial year ending June 30, on the back of a 51 per cent rise in sales in the US.
It reported a 25 per cent rise in net sales to Rs 1,137 crore during the quarter, up from Rs 908 crore in the corresponding quarter last year. US sales were up by 51 per cent to Rs 223 crore. It launched Anasterazole Tablets, Tamsulosin Caps and Famotidine Suspension in the US market.
Ashok Leyland net up 15-fold
Ashok Leyland, the commercial vehicle maker, today reported a more than 15-fold rise in net profit at Rs 123 crore for the quarter ended June 30, against Rs 7.7 crore in the corresponding quarter last year. Net sales rose 157.32 per cent to Rs 2,348 crore from Rs 912.5 crore.
R Seshasayee, managing director of Ashok Leyland, said, “The year is promising and growth will also be fuelled by private consumption and expect to post 15 per cent growth.”
Oil India net dips 32%
Oil India Ltd (OIL), the state-run oil exploration company, today posted a 32 per cent dip in net profit for the June quarter on higher subsidy burden, rupee depreciation and production cut.
Net profit stood at Rs 501.1 crore, compared to Rs 739.7 crore in same quarter last year. Turnover was down by 21 per cent to Rs 1,523.4 crore.
“The bottom line and top line have taken a hit in line with the fall in crude oil production, the decline in crude oil price realisation and rupee depreciation,” T K Ananth Kumar, director (finance), said.
|
|
|
|
|
|
|
|
|
|
 Read Business news in |  |
|
|
|
|
|
|
Advertisements |
|
|
|
|
|
|
|
|
|
|
Content Guide
